Sonis ST: Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol. 1998, 34 (1): 39-43. 10.1016/S1368-8375(97)00053-5.
Article
CAS
PubMed
Google Scholar
Carneiro-Filho BA, Lima IPF, Araujo DH, Cavalcante MC, Carvalho GHP, Brito GAC, Lima V, Monteiro SMN, Santos FN, Ribeiro RA, et al: Intestinal barrier function and secretion in methotrexate-induced rat intestinal mucositis. Dig Dis Sci. 2004, 49 (1): 65-72.
Article
CAS
PubMed
Google Scholar
Keefe DM, Brealey J, Goland GJ, Cummins AG: Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut. 2000, 47 (5): 632-637. 10.1136/gut.47.5.632.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kadowaki S, Yamaguchi K: Chemotherapy-induced stomatitis and diarrhea. Gan To Kagaku Ryoho. 2011, 38 (11): 1761-1766.
PubMed
Google Scholar
Howden CW, Robertson C, Duncan A, Morris AJ, Russell RI: Comparison of different measurements of intestinal permeability in inflammatory bowel disease. Am J Gastroenterol. 1991, 86 (10): 1445-1449.
CAS
PubMed
Google Scholar
Nagahama S, Korenaga D, Honda M, Inutsuka S, Sugimachi K: Assessment of the intestinal permeability after a gastrectomy and the oral administration of anti-cancer drugs in rats: nitric oxide release in response to gut injury. Surgery. 2002, 131 (1 Suppl): S92-97.
Article
PubMed
Google Scholar
Dvorak J, Melichar B, Hyspler R, Krcmova L, Urbanek L, Kalabova H, Kasparova M, Solichova D: Intestinal permeability, vitamin A absorption, alpha-tocopherol, and neopterin in patients with rectal carcinoma treated with chemoradiation. Med Oncol. 2010, 27 (3): 690-696. 10.1007/s12032-009-9270-4.
Article
CAS
PubMed
Google Scholar
Melichar B, Zezulova M: The significance of altered gastrointestinal permeability in cancer patients. Curr Opin Support Palliat Care. 2011, 5 (1): 47-54. 10.1097/SPC.0b013e328343a043.
Article
PubMed
Google Scholar
Melichar B, Hyspler R, Dragounova E, Dvorak J, Kalabova H, Ticha A: Gastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinum. BMC Cancer. 2007, 7: 155-10.1186/1471-2407-7-155.
Article
PubMed
PubMed Central
Google Scholar
Kim R, Osaki A, Toge T: Current and future roles of neoadjuvant chemotherapy in operable breast cancer. Clin Breast Cancer. 2005, 6 (3): 223-232. 10.3816/CBC.2005.n.024. discussion 233–224
Article
PubMed
Google Scholar
Tripathi A, Lammers KM, Goldblum S, Shea-Donohue T, Netzel-Arnett S, Buzza MS, Antalis TM, Vogel SN, Zhao A, Yang S, et al: Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci USA. 2009, 106 (39): 16799-16804. 10.1073/pnas.0906773106.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sapone A, de Magistris L, Pietzak M, Clemente MG, Tripathi A, Cucca F, Lampis R, Kryszak D, Carteni M, Generoso M, et al: Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes. 2006, 55 (5): 1443-1449. 10.2337/db05-1593.
Article
CAS
PubMed
Google Scholar
Drucker DJ: Gut adaptation and the glucagon-like peptides. Gut. 2002, 50 (3): 428-435. 10.1136/gut.50.3.428.
Article
CAS
PubMed
PubMed Central
Google Scholar
Benjamin MA, McKay DM, Yang PC, Cameron H, Perdue MH: Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse. Gut. 2000, 47 (1): 112-119. 10.1136/gut.47.1.112.
Article
CAS
PubMed
PubMed Central
Google Scholar
Boushey RP, Yusta B, Drucker DJ: Glucagon-like peptide (GLP)-2 reduces chemotherapy-associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor. Cancer Res. 2001, 61 (2): 687-693.
CAS
PubMed
Google Scholar
Chaet MS, Arya G, Ziegler MM, Warner BW: Epidermal growth factor enhances intestinal adaptation after massive small bowel resection. J Pediatr Surg. 1994, 29 (8): 1035-1038. 10.1016/0022-3468(94)90274-7. discussion 1038–1039
Article
CAS
PubMed
Google Scholar
Huang FS, Kemp CJ, Williams JL, Erwin CR, Warner BW: Role of epidermal growth factor and its receptor in chemotherapy-induced intestinal injury. Am J Physiol Gastrointest Liver Physiol. 2002, 282 (3): G432-442.
Article
CAS
PubMed
Google Scholar
Fahim MA, Kataya H, El-Kharrag R, Amer DA, al-Ramadi B, Karam SM: Ghrelin attenuates gastrointestinal epithelial damage induced by doxorubicin. World J Gastroenterol. 2011, 17 (33): 3836-3841. 10.3748/wjg.v17.i33.3836.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sonis ST, Eilers JP, Epstein JB, LeVeque FG, Liggett WH, Mulagha MT, Peterson DE, Rose AH, Schubert MM, Spijkervet FK, et al: Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis study group. Cancer. 1999, 85 (10): 2103-2113. 10.1002/(SICI)1097-0142(19990515)85:10<2103::AID-CNCR2>3.0.CO;2-0.
Article
CAS
PubMed
Google Scholar
Svedlund J, Sjodin I, Dotevall G: GSRS - a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988, 33 (2): 129-134. 10.1007/BF01535722.
Article
CAS
PubMed
Google Scholar
Arbuckle RB, Huber SL, Zacker C: The consequences of diarrhea occurring during chemotherapy for colorectal cancer: a retrospective study. Oncologist. 2000, 5 (3): 250-259. 10.1634/theoncologist.5-3-250.
Article
CAS
PubMed
Google Scholar
Generoso M, De Rosa M, De Rosa R, De Magistris L, Secondulfo M, Fiandra R, Carrato R, Carteni M: Cellobiose and lactulose coupled with mannitol and determined using ion-exchange chromatography with pulsed amperometric detection are reliable probes for investigation of intestinal permeability. J Chromatogr B, Anal Tech Biomed Life Sci. 2003, 783 (2): 349-357. 10.1016/S1570-0232(02)00766-3.
Article
CAS
Google Scholar
Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer DH: Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology. 2003, 28 (7): 916-931. 10.1016/S0306-4530(02)00108-7.
Article
CAS
PubMed
Google Scholar
Edlund P, Ahlgren J, Bjerre K, Andersson M, Bergh J, Mouridsen H, Holmberg SB, Bengtsson N-O, Jakobsen E, Moller S, et al: Dose-tailoring of FEC adjuvant chemotherapy based on leukopenia is feasible and well tolerated. Toxicity and dose intensity in the scandinavian breast group phase 3 adjuvant trial SBG 2000–1. Acta Oncol. 2011, 50 (3): 329-337. 10.3109/0284186X.2011.554435.
Article
CAS
PubMed
Google Scholar
Drago S, El Asmar R, Di Pierro M, Grazia Clemente M, Tripathi A, Sapone A, Thakar M, Iacono G, Carroccio A, D’Agate C, et al: Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scand J Gastroenterol. 2006, 41 (4): 408-419. 10.1080/00365520500235334.
Article
CAS
PubMed
Google Scholar
Hamada K, Shitara Y, Sekine S, Horie T: Zonula Occludens-1 alterations and enhanced intestinal permeability in methotrexate-treated rats. Cancer Chemother Pharmacol. 2010, 66 (6): 1031-1038. 10.1007/s00280-010-1253-9.
Article
CAS
PubMed
Google Scholar
Ziegler TR, Estivariz CF, Jonas CR, Gu LH, Jones DP, Leader LM: Interactions between nutrients and peptide growth factors in intestinal growth, repair, and function. JPEN J Parenter Enteral Nutr. 1999, 23 (6 Suppl): S174-183. 10.1177/014860719902300602.
Article
CAS
PubMed
Google Scholar
Baksheev L, Fuller PJ: Humoral factors in intestinal adaptation. Trends Endocrinol Metab. 2000, 11 (10): 401-405. 10.1016/S1043-2760(00)00307-6.
Article
CAS
PubMed
Google Scholar
Cameron HL, Yang P-C, Perdue MH: Glucagon-like peptide-2-enhanced barrier function reduces pathophysiology in a model of food allergy. Am J Physiol Gastrointest Liver Physiol. 2003, 284 (6): G905-912.
Article
CAS
PubMed
Google Scholar
Yusta B, Holland D, Koehler JA, Maziarz M, Estall JL, Higgins R, Drucker DJ: ErbB signaling is required for the proliferative actions of GLP-2 in the murine gut. Gastroenterology. 2009, 137 (3): 986-996. 10.1053/j.gastro.2009.05.057.
Article
CAS
PubMed
Google Scholar
Al-Nafussi AI, Wright NA: The effect of epidermal growth factor (EGF) on cell proliferation of the gastrointestinal mucosa in rodents. Virchows Arch B Cell Pathol Incl Mol Pathol. 1982, 40 (1): 63-69. 10.1007/BF02932851.
Article
CAS
PubMed
Google Scholar
Drucker DJ, Erlich P, Asa SL, Brubaker PL: Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci USA. 1996, 93 (15): 7911-7916. 10.1073/pnas.93.15.7911.
Article
CAS
PubMed
PubMed Central
Google Scholar
Scott RB, Kirk D, MacNaughton WK, Meddings JB: GLP-2 augments the adaptive response to massive intestinal resection in rat. Am J Physiol. 1998, 275 (5 Pt 1): G911-921.
CAS
PubMed
Google Scholar
Lee KK, Jo HJ, Hong JP, Lee S-W, Sohn JS, Moon SY, Yang SH, Shim H, Lee SH, Ryu S-H, et al: Recombinant human epidermal growth factor accelerates recovery of mouse small intestinal mucosa after radiation damage. Int J Radiat Oncol Biol Phys. 2008, 71 (4): 1230-1235. 10.1016/j.ijrobp.2008.03.041.
Article
CAS
PubMed
Google Scholar
Torres S, Thim L, Milliat F, Vozenin-Brotons M-C, Olsen UB, Ahnfelt-Ronne I, Bourhis J, Benderitter M, Francois A: Glucagon-like peptide-2 improves both acute and late experimental radiation enteritis in the rat. Int J Radiat Oncol Biol Phys. 2007, 69 (5): 1563-1571. 10.1016/j.ijrobp.2007.08.051.
Article
CAS
PubMed
Google Scholar
Kitchen PA, Goodlad RA, FitzGerald AJ, Mandir N, Ghatei MA, Bloom SR, Berlanga-Acosta J, Playford RJ, Forbes A, Walters JRF: Intestinal growth in parenterally-fed rats induced by the combined effects of glucagon-like peptide 2 and epidermal growth factor. JPEN J Parenter Enteral Nutr. 2005, 29 (4): 248-254. 10.1177/0148607105029004248.
Article
CAS
PubMed
Google Scholar
Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999, 402 (6762): 656-660. 10.1038/45230.
Article
CAS
PubMed
Google Scholar
Andreis PG, Malendowicz LK, Trejter M, Neri G, Spinazzi R, Rossi GP, Nussdorfer GG: Ghrelin and growth hormone secretagogue receptor are expressed in the rat adrenal cortex: evidence that ghrelin stimulates the growth, but not the secretory activity of adrenal cells. FEBS Lett. 2003, 536 (1–3): 173-179.
Article
CAS
PubMed
Google Scholar
Gonzalez-Rey E, Chorny A, Delgado M: Therapeutic action of ghrelin in a mouse model of colitis. Gastroenterology. 2006, 130 (6): 1707-1720. 10.1053/j.gastro.2006.01.041.
Article
CAS
PubMed
Google Scholar
Peracchi M, Conte D, Terrani C, Pizzinelli S, Gebbia C, Cappiello V, Spada A, Bardella MT: Circulating ghrelin levels in celiac patients. Am J Gastroenterol. 2003, 98 (11): 2474-2478. 10.1111/j.1572-0241.2003.07709.x.
Article
CAS
PubMed
Google Scholar
Sharma R, Tobin P, Clarke SJ: Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhea. Lancet Oncol. 2005, 6 (2): 93-102. 10.1016/S1470-2045(05)01735-3.
Article
CAS
PubMed
Google Scholar
Zhu X, Zhou A, Dey A, Norrbom C, Carroll R, Zhang C, Laurent V, Lindberg I, Ugleholdt R, Holst JJ, et al: Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects. Proc Natl Acad Sci USA. 2002, 99 (16): 10293-10298. 10.1073/pnas.162352599.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wojdemann M, Wettergren A, Hartmann B, Holst JJ: Glucagon-like peptide-2 inhibits centrally induced antral motility in pigs. Scand J Gastroenterol. 1998, 33 (8): 828-832. 10.1080/00365529850171486.
Article
CAS
PubMed
Google Scholar
L’Heureux MC, Brubaker PL: Therapeutic potential of the intestinotropic hormone, glucagon-like peptide-2. Ann Med. 2001, 33 (4): 229-235. 10.3109/07853890108998750.
Article
PubMed
Google Scholar